Vantage Investment Advisors’s CRISPR Therapeutics CRSP Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2018
Q3
$9K Hold
200
﹤0.01% 548
2018
Q2
$12K Buy
+200
New +$12K ﹤0.01% 500